Nils Billestrup

Nils Billestrup

Professor


  1. Published

    Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt

    Størling, Joachim, Binzer, J., Andersson, A., Züllig, R. A., Tonnesen, M., Knudsen, R. L. P., Spinas, G. A., Sandler, S., Billestrup, Nils & Mandrup-Poulsen, Thomas, 1 Oct 2005, In: Diabetologia. 48, 10, p. 2039-50 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B

    Stofega, M. R., Herrington, J., Billestrup, Nils & Carter-Su, C., Sep 2000, In: Molecular endocrinology (Baltimore, Md.). 14, 9, p. 1338-50 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation

    Stefaneanu, L., Kovacs, K., Horvath, E., Asa, S. L., Losinski, N. E., Billestrup, Nils, Price, J. & Vale, W., Nov 1989, In: Endocrinology. 125, 5, p. 2710-8 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH

    Smit, L. S., Meyer, D. J., Billestrup, Nils, Norstedt, G., Schwartz, J. & Carter-Su, C., May 1996, In: Molecular endocrinology (Baltimore, Md.). 10, 5, p. 519-33 15 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes

    Skarbaliene, J., Rigbolt, K. T., Fosgerau, K. & Billestrup, Nils, 15 Nov 2017, In: European Journal of Pharmacology. 815, p. 181-189 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    The Anti-diabetic Effects of GLP-1-gastrin Dual Agonist ZP3022 in ZDF rats

    Skarbaliene, J., Secher, T., Jelsing, J., Ansarullah, Neerup, T. S. R., Billestrup, Nils & Fosgerau, K., Jul 2015, In: Peptides. 69, p. 47-55 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Identification of corticotropin-releasing factor (CRF) target cells and effects of dexamethasone on binding in anterior pituitary using a fluorescent analog of CRF

    Schwartz, J., Billestrup, Nils, Perrin, M., Rivier, J. & Vale, W., Nov 1986, In: Endocrinology. 119, 5, p. 2376-82 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    The effect of suppressor of cytokine signaling 3 on GH signaling in beta-cells

    Rønn, S. G., Hansen, J. A., Lindberg, K., Karlsen, A. E. & Billestrup, Nils, Sep 2002, In: Molecular endocrinology (Baltimore, Md.). 16, 9, p. 2124-34 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection

    Rønn, S. G., Börjesson, A., Bruun, C., Heding, P. E., Frobøse, H., Mandrup-Poulsen, Thomas, Karlsen, A. E., Rasschaert, J., Sandler, S. & Billestrup, Nils, 2008, In: Diabetologia. 51, 10, p. 1873-1882 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling

    Ridderstråle, M., Amstrup, J., Hilton, D. J., Billestrup, Nils & Tornqvist, H., Mar 2003, In: Hormone and Metabolic Research. Supplement. 35, 3, p. 169-77 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 15311848